Abstract
Cobalt decreases blood glucose in diabetic rats but the mechanisms involved are unclear. To determine the contribution of glycogen metabolism to glycemia-lowering effect, glycogen contents of liver and muscle in the streptozotocin-induced diabetic rats were determined. The liver glycogen was depleted in diabetic rats. But when cobalt was administered to the rats, the glycogen returned to the level of healthy rats, concomitantly with the decrease in blood glucose. The cobalt treatment had no effect on the muscle glycogen in the diabetic rats. The tissue-specific responses of glycogen metabolism suggest the involvement of suppressed glucagon signaling due to cobalt treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Nordlie RC, Foster JD, Lange AJ: Regulation of glucose production by the liver. Annu Rev Nutr 19: 379–406, 1999
Zierler K: Whole body glucose metabolism. Am J Physiol 1: 409–426, 1999
Badr GA, Zhang JZ, Tang J, Kern TS, Ismail-Beigi F: Glut1 and glut3 expression, but not capillary density, is increased by cobalt chloride in rat cerebrum and retina. Brain Res Mol Brain Res 64: 24–33, 1999
Chavez JC, LaManna JC: Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J Neurosci 22: 8922–8931, 2002
Lee M, Hwang JT, Lee HJ, Jung SN, Kang I, Chi SG, Kim SS, Ha J: AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J Biol Chem 278: 39653–39661, 2003
Ybarra J, Behrooz A, Gabriel A, Koseoglu MH, Ismail-Beigi F: Glycemia-lowering effect of cobalt chloride in the diabetic rat: increased GLUT1 mRNA expression. Mol Cell Endocrinol 133: 151–160, 1997
Saker F, Ybarra J, Leahy P, Hanson RW, Kalhan SC, Ismail-Beigi F: Glycemia-lowering effect of cobalt chloride in the diabetic rat: role of decreased gluconeogenesis. Am J Physiol 1: 984–991, 1998
Endoh H, Kaneko T, Nakamura H, Doi K, Takahashi E: Improved cardiac contractile functions in hypoxia-reoxygenation in rats treated with low concentration Co(2+). Am J Physiol Heart Circ Physiol 6: 2713–2719, 2000
Chen V, Ianuzzo CD: Dosage effect of streptozotocin on rat tissue enzyme activities and glycogen concentration. Can J Physiol Pharmacol 60:1251–1256, 1982
Eaton RP: Cobalt chloride-induced hyperlipemia in the rat: effects on intermediary metabolism. Am J Physiol 222: 1550–1557, 1972
Yang L, Crans D, Miller S, la Cour A, Anderson O, KaszynskiP, Godzala M, Austin L, Willsky G: Cobalt(II) and cobalt(III) dipicolinate complexes: solid state, solution, and in vivo insulin-like properties. Inorg Chem 41: 4859–4871, 2002
Mick G, Wang X, McCormick K: White adipocyte vascular endothelial growth factor: regulation by insulin. Endocrinology 143: 948–953, 2002
Johnson DG, Goebel CU, Hruby VJ, Bregman MD, Trivedi D: Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. Science 215: 1115–1116, 1982
Hansen LH, Abrahamsen N, Nishimura E: Glucagon receptor mRNA distribution in rat tissues. Peptides 16: 1163–1166, 1995
Mine T, Kimura S, Osawa H, Ogata E: Inhibition of the glycogenolytic effects of alpha-adrenergic stimulation and glucagon by cobalt ions in perfused rat liver. Life Sci 38: 2285–2292, 1986
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nomura, Y., Okamoto, Si., Sakamoto, M. et al. Effect of cobalt on the liver glycogen content in the streptozotocin-induced diabetic rats. Mol Cell Biochem 277, 127–130 (2005). https://doi.org/10.1007/s11010-005-5777-y
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1007/s11010-005-5777-y